Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2005
08/31/2005EP1568697A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof
08/31/2005EP1568695A1 3,4-Dihydroquinazoline derivatives as T-type calcium channel blockers and method of preparing the same
08/31/2005EP1568692A1 (pyridin-4-yl)alkyl-amides as TNF-alpha production inhibitors
08/31/2005EP1568691A1 Erythropoietin production accelerator
08/31/2005EP1568382A1 REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND &bgr;-BLOCKER
08/31/2005EP1568381A1 Remedy for hormone-dependent cancer
08/31/2005EP1568380A1 Preventive or remedy for diseases caused by hyperglycemia
08/31/2005EP1568379A1 Medicinal preparation having chemotherapeutic encapsulated therein
08/31/2005EP1568377A1 Cysteine protease inhibitor
08/31/2005EP1568376A2 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
08/31/2005EP1568367A1 Compounds effecting glucokinase
08/31/2005EP1568365A1 Warm poultice
08/31/2005EP1568359A1 Drug delivery system using subconjunctival depot
08/31/2005EP1567529A2 Pseudopolymorphic forms of a hiv protease inhibitor
08/31/2005EP1567523A1 Indolyl derivatives
08/31/2005EP1567497A2 Pyridines for treating injured mammalian nerve tissue
08/31/2005EP1567160A2 Method of treatment of myocardial infarction
08/31/2005EP1430057B1 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives
08/31/2005EP1397359B1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
08/31/2005EP1395576B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
08/31/2005EP1392288B1 Medicament containing an effector of the glutathione metabolism (ampbroxol) together with alpha-lipoic acid for treating diabetes mellitus
08/31/2005EP1370569B1 Process for preparing n6-substituted aminopurine ribofuranose nucleosides
08/31/2005EP1366038B1 Cdk-1 inhibitor oxindoles and the application thereof in therapeutics
08/31/2005EP1363901A4 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles
08/31/2005EP1363516B1 An improved process for preparing simvastatin
08/31/2005EP1347978B1 Novel substituted imidazotriazinones as pde ii-inhibitors
08/31/2005EP1278723B1 P-(sulfonyl)-aryl and -heteroaryl amines
08/31/2005EP1268445B1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
08/31/2005EP1240168B1 Bicyclic inhibitors of glycogen synthase kinase 3
08/31/2005EP1230925B1 Use of a trifluridine derivative alone or combined with a thymidine phosphorylase inhibitor for the treatment of hiv
08/31/2005EP1221444B1 Fused imidazole compounds and remedies for diabetes mellitus
08/31/2005EP1173475B1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
08/31/2005EP1169060B1 Sodium channel blocker compositions and the use thereof
08/31/2005EP1163212B1 Amide derivatives
08/31/2005EP1156047B1 6-substituted-7- heteroquinoxaline carboxylic acid derivatives and addition salts thereof and processes for the preparation of both
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP1070048B1 Calcilytic compounds
08/31/2005EP1058542B1 Method for producing encased spherical granular grains comprising prostane derivatives
08/31/2005EP1003497B1 Il-8 receptor antagonists
08/31/2005EP0989973B1 Chalcones having antiproliferative activity
08/31/2005EP0984780B1 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
08/31/2005EP0977550B1 Use of at least one irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
08/31/2005EP0888333B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
08/31/2005EP0882718B1 Benzimidazole derivatives
08/31/2005CN1662664A Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
08/31/2005CN1662655A Beta glucan-containing fat and oil compositions and novel microorganism capable of producing beta-glucan
08/31/2005CN1662654A Preparation of microbial oil containing polyunsaturated fatty acids
08/31/2005CN1662642A Pasteurisation process for microbial cells and microbial oil
08/31/2005CN1662549A Glucocorticoid receptor ligands for the treatment of metabolic disorders
08/31/2005CN1662548A Regeneration of endogenous myocardial tissue by induction of neovascularization
08/31/2005CN1662544A Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662542A Heterocyclic compounds
08/31/2005CN1662541A Furyl compounds
08/31/2005CN1662539A [1, 4]diazocino [7, 8, 1-hi]indole derivatives as antipsychotic and antiobesity agents
08/31/2005CN1662537A Pyrazolo (1, 5-a) pyrimidine derivative and nad(p)h oxidase inhibitor containing the same
08/31/2005CN1662534A 1, 2, 3, 4, 7, 8-hexahydro-6h-[1, 4]diazepino[6, 7, 1-1j]quinoline derivatives as antipsychotic and antiobesity agents
08/31/2005CN1662531A Hetero-bicyclic compounds
08/31/2005CN1662530A Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
08/31/2005CN1662524A Indole derivatives useful as histamine h3 antagonists
08/31/2005CN1662523A Novel process
08/31/2005CN1662522A Novel compounds, their use and preparation
08/31/2005CN1662521A Compounds useful for the treatment of obesity, type ii diabetes and cns disorders
08/31/2005CN1662516A N, N-disubstituted diazocycloalkanes
08/31/2005CN1662514A Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662513A 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same
08/31/2005CN1662511A Pharmaceutical salts of reboxetine
08/31/2005CN1662509A Pyrrolo-triazine aniline compounds useful as kinase inhibitors
08/31/2005CN1662508A Compounds, compositions and methods
08/31/2005CN1662506A Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
08/31/2005CN1662505A Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
08/31/2005CN1662504A 2, 5-disubstituted 3-mercaptopentanoic acid
08/31/2005CN1662502A Cyanoguanidine produgs
08/31/2005CN1662500A Novel azasugar derivative and drug containing the same as the active ingredient
08/31/2005CN1662497A Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
08/31/2005CN1662496A Cannabinoid receptor agonists
08/31/2005CN1662490A Nitrooxyderivatives of cyclooxygenase-2 inhibitors
08/31/2005CN1662487A Amide linker peroxisome proliferator activated receptor modulators
08/31/2005CN1662280A Method and apparatus for ultrasound treatment of connective tissue
08/31/2005CN1662262A Decoys for treating and/or preventing Th2 cytokine-related allergic diseases, GATA3 mutant proteins and pharmaceutical compositions comprising the decoys and the proteins
08/31/2005CN1662260A Process for producing sustained-release composition
08/31/2005CN1662257A Combination of PDE5 inhibitors with angiotensin II receptor antagonists
08/31/2005CN1662251A Adjuvant enhanced immunotherapy
08/31/2005CN1662249A Osteopontin, oligodendrocytes and myelination
08/31/2005CN1662248A Compositions against inflammatory processes
08/31/2005CN1662246A Combination therapy wherein a serotonin reuptake inhibitor is used
08/31/2005CN1662242A Pharmaceutical compositions for the treatment of diseases related to neurotrophines
08/31/2005CN1662241A Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
08/31/2005CN1662239A Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor
08/31/2005CN1662237A Controlled-release drug composition
08/31/2005CN1662236A Inhibitors of histone deacetylase
08/31/2005CN1662232A Medicinal compositions improving brain function and method for improving brain function
08/31/2005CN1662231A Prevention and treatment of functional somatic disorders, including stress-related disorders
08/31/2005CN1662154A Probiotics and oral tolerance
08/31/2005CN1661109A Novel targets for obesity from skeletal muscle
08/31/2005CN1660911A Connective tissue growth factor fragments and methods and uses thereof
08/31/2005CN1660849A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/31/2005CN1660840A Phthalazine derivatives for treating inflammatory diseases
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660820A 3, 4-dihydroquinazoline derivatives as t-type calcium channel blockers and method of preparing the same
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
1 ... 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 ... 1564